Data / Form D filings / Solarea Bio, Inc.
Solarea Bio, Inc.: Form D filings
Solarea Bio, Inc., a biotechnology company in Waltham, MA, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on November 20, 2025, reports $9.9 million sold of an offering with no set size to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 BEAVER STREET, SUITE 308, Waltham, MA, 02453
- Phone
- (585) 704-8069
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1823902
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | New notice | Indefinite | $9,910,397 | 5 | Nov 4, 2025 | sec.gov | |
| Sep 10, 2024 | New notice | Indefinite | $1,000,000 | 1 | Aug 27, 2024 | sec.gov | |
| May 9, 2023 | New notice | $25,000,000 | $14,999,999 | $10,000,001 | 4 | May 3, 2023 | sec.gov |
| Sep 11, 2020 | New notice | $14,826,612 | $11,326,613 | $3,499,999 | 15 | Aug 31, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| NEAL BHADKAMKAR | Director | |
| MATTHEW WALKER | Director | |
| ANULA JAYASURIYA | Director | |
| GREGORY SIECZKIEWICZ | Director | |
| CATHERINE BALSAM-SCHWABER | Executive Officer, Director | |
| ERIC SCHOTT | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Solarea Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.